Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Relmada Therapeutics | RLMD | Aug 30, 2024 | 2.80 | +6.06 |
RELX ADR | RELX | Aug 30, 2024 | 46.66 | -1.02 |
Remitly Global | RELY | Aug 30, 2024 | 13.65 | -0.73 |
Renaissance Ipo ETF | IPO | Aug 30, 2024 | 41.77 | +1.06 |
RenaissanceRe | RNR | Aug 30, 2024 | 254.79 | -1.03 |
RenaissanceRe G Pref | RNR-G | Aug 30, 2024 | 18.26 | -2.09 |
RenaissanceRe Holding F Pref | RNR-F | Aug 30, 2024 | 24.60 | -1.32 |
Renalytix ADR | RNLX | Aug 30, 2024 | 0.31 | +7.31 |
Renasant | RNST | Aug 30, 2024 | 35.00 | +1.36 |
Reneo Pharmaceuticals | RPHM | Aug 30, 2024 | 1.48 | -1.33 |
ReNew Energy Global A Shares | RNW | Aug 30, 2024 | 5.62 | +0.18 |
Renn Fund | RCG | Aug 30, 2024 | 1.88 | +1.35 |
Renovaro Biosciences | RENB | Aug 30, 2024 | 0.60 | -8.65 |
RenovoRx | RNXT | Aug 30, 2024 | 1.02 | -0.97 |
Rent The Runway A | RENT | Aug 30, 2024 | 13.32 | +9.00 |
Rentokil Initial ADR | RTO | Aug 30, 2024 | 32.23 | -0.09 |
Repare Therapeutics | RPTX | Aug 30, 2024 | 2.91 | -3.32 |
Repay A | RPAY | Aug 30, 2024 | 8.46 | +0.24 |
Repligen | RGEN | Aug 30, 2024 | 150.93 | +0.12 |
Replimune Group | REPL | Aug 30, 2024 | 10.17 | -8.05 |
ReposiTrak | TRAK | Aug 30, 2024 | 19.45 | +1.35 |
Republic Bancorp A | RBCAA | Aug 30, 2024 | 63.90 | -0.93 |
Republic Services | RSG | Aug 30, 2024 | 208.21 | +1.10 |
Research Frontiers | REFR | Aug 30, 2024 | 2.16 | -1.82 |
Research Solutions | RSSS | Aug 30, 2024 | 2.78 | -0.36 |
Reservoir Media | RSVR | Aug 30, 2024 | 7.76 | +0.26 |
ReShape Lifesciences | RSLS | Aug 30, 2024 | 0.16 | +0.19 |
Resideo Technologies | REZI | Aug 30, 2024 | 20.16 | +1.26 |
ResMed | RMD | Aug 30, 2024 | 245.02 | +0.76 |
Resources Connection | RGP | Aug 30, 2024 | 10.43 | +0.68 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.